Clinical and cortical decline in the aphasic variant of Alzheimer's disease
- PMID: 30765195
- PMCID: PMC6461481
- DOI: 10.1016/j.jalz.2018.12.003
Clinical and cortical decline in the aphasic variant of Alzheimer's disease
Abstract
Introduction: Primary progressive aphasia (PPA) displays variable progression trajectories that require further elucidation.
Methods: Longitudinal quantitation of atrophy and language over 12 months was completed for PPA patients with and without positive amyloid PET (PPAAβ+ and PPAAβ-), an imaging biomarker of underlying Alzheimer's disease.
Results: Over 12 months, both PPA groups showed significantly greater cortical atrophy rates in the left versus right hemisphere, with a more widespread pattern in PPAAβ+. The PPAAβ+ group also showed greater decline in performance on most language tasks. There was no obligatory relationship between the logopenic PPA variant and amyloid status. Effect sizes from quantitative MRI data were more robust than neuropsychological metrics.
Discussion: Preferential language network neurodegeneration is present in PPA irrespective of amyloid status. Clinical and anatomical progression appears to differ for PPA due to Alzheimer's disease versus non-Alzheimer's disease neuropathology, a distinction that may help to inform prognosis and the design of intervention trials.
Keywords: Amyloid PET; Biomarker; FreeSurfer; Frontotemporal dementia; Frontotemporal lobar degeneration; Neuropsychology; Primary progressive aphasia; Progression; Volumetric MRI.
Copyright © 2019 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.
Figures



References
-
- Mesulam MM. Primary Progressive Aphasia: A Language-Based Dementia. N Engl J Med 2003;349:1535–42. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical